Regenerative Medicine Foundation

SUPPORTING REGENERATIVE MEDICINE

Our mission is to accelerate regenerative medicine to improve health and deliver cures
previous arrow
next arrow
Slider
Regenerative Medicine

Regenerative Medicine

A new paradigm of medicine that relies on stem cells capacity to regenerate, regrow, and fully heal damaged tissues and organs in our bodies.
Ethics and Policy

Ethical Advancement

We are committed to the ethical advancement of an innovative medicine powered by regenerative, restorative, and curative technologies.
Improving Health

Improve Health

All we do is in service of health, life, and the alleviation of human suffering.
Deliver Cures

Deliver Cures

Alleviating the suffering and restoring the hope of patients, and of their loved ones, is what fuels our passion and our work.

Latest News, Opinions and Video

Intranasal delivery of MSCs provides hope for treating Alzheimer’s disease

Durham, NC – In the search for a cure for Alzheimer's disease, mesenchymal stem cells and their derived extracellular vesicles (MSC-EVs) offer much...

MSC Therapy for Acute Respiratory Distress Syndrome; It’s Time to Accelerate Clinical Trials for COVID-19 Patients in Need

Washington, DC (June 3, 2020) – A new systematic review and meta-analysis of clinical studies using mesenchymal stromal cells (MSCs) led by a team...

Stem cells from placental amniotic membrane slow lung scarring in pulmonary fibrosis

Durham, NC – In a study released today in STEM CELLS Translational Medicine (SCTM), a team led by researchers at the Eugenia Menni Research Centre...
Cord Blood Study Provides Insights on Benefits, Limitations for Autism Treatment

Cord Blood Study Provides Insights on Benefits, Limitations for Autism Treatment

Children with autism without intellectual disability may benefit, but more research is needed DURHAM, N.C. -- In a recent study, Duke researchers...

Clinical trial shows ability of stem cell-based topical solution to regrow hair

Photo caption, "A more enriched adipose-derived stem cells-constituent extract (ADSC-CE) with stem cell proteins is obtained by disruption of the...
RMMS: The Regenerative Medicine Manufacturing Society Will Target Unmet Needs in 3D Bioprinting

RMMS: The Regenerative Medicine Manufacturing Society Will Target Unmet Needs in 3D Bioprinting

by Vanesa Listek 3D Printing | Bioprinting To deal with the challenges in regenerative medicine, in 2018, pioneer bioprinting expert Anthony Atala...

Study shows stem cells constitute alternative approach for treating corneal scarring

Durham, NC – Infection, inflammation, trauma, disease, contact lenses – all of these and more can lead to corneal scarring, which according to the...
California stem cell advocates submit signatures for .5 billion bond measure

California stem cell advocates submit signatures for $5.5 billion bond measure

By Dustin Gardiner- May 5, 2020, San Francisco Chronicle Supporters of a proposed $5.5 billion bond measure that would keep California’s stem cell...
Mesoblast’s Stem Cell Therapy Shows 83% Survival in Ventilator-Dependent COVID-19 Patients

Mesoblast’s Stem Cell Therapy Shows 83% Survival in Ventilator-Dependent COVID-19 Patients

April 24, 2020 - By Mark Terry - Melbourne, Australia and New York-based Mesoblast Limited announced that in a study of COVID-19 patients with...

CIRM Board Funds its First Clinical Study for COVID-19

April 24, 2020 / Yimy Villa Dr. John Zaia, City of hope The governing Board of the California Institute for Regenerative Medicine (CIRM) continued...

Working with Policy Leaders in the United States

Making safe and effective treatments available for patients

Regenerative cellular therapies represent the next generation of groundbreaking treatments that are showing great promise in cardiology, neurology, oncology, orthopedics, ophthalmology, and other areas. Several well-designed clinical trials are being conducted under FDA investigational new drug (IND) protocols. At the same time, a handful of clinics have caused patient harm or made questionable claims, taking advantage of vulnerable patients and casting a negative light on this emerging science and industry.
Marks-Patterson-Siegel-and-Marchibroda Washington DC Policy Meeting
Regenerative Medicine Foundation Logo

What We Do

Conferences

We Produce the World Stem Cell Summit, the RegMed Capital Conference, the Stem Cell Action Awards, and other events.

Patient Advocacy

We inform, celebrate and mobilize the global advocacy movement consisting of patients, advocates and medical philanthropies, all supporting regenerative medicine, including stem cell research and cell therapies.

Policy

Since 2003 we have a track record fostering a supportive regulatory and societal framework for regenerative medicine.

Outreach

We educate the scientific community, public and media through our official, peer-reviewed, journal partner STEM CELLS Translational Medicine, the Regenerative Medicine Weekly Newsletter, social media channels, speaking engagements and media interviews.

A Trusted Network

Regenerative Medicine Foundation unites the world’s leading researchers, medical centers, universities, labs, businesses, funders, policymakers, experts in law, regulation and ethics, medical philanthropies, and patient organizations.
The Regenerative Medicine Foundation is a non-profit organization, granted tax-exempt status under Section 501(c)(3) of the United States Internal Revenue Code. Contributions are tax-deductible to the extent allowable by law.

Join Our Mailing List

Pin It on Pinterest